At the IGTP TODAY

News

Two IGTP groups lead a European analysis to understand key factors for digitalisation in practice environments

The research groups in Nursing Care (NURECARE) and Innovation, Health Economics and Digital Transformation (INEDIT) from the IGTP are leading the publication of the first report on the key factors for introducing digital technologies in professional nursing practice environments. Through this effort, professionals from the Germans Trias Hospital are participating for the first time in the design of a comprehensive analysis of the required changes, while also offering recommendations to ensure the success of any initiative aimed at incorporating these technologies into hospitals.

- Campus Can Ruti, Research

Tuberculosis BCG vaccine found ineffective against COVID-19 in healthcare workers

An international trial has investigated the potential immune-boosting effects of the tuberculosis BCG vaccine against COVID-19. The results show that the risk of developing the disease during the first six months after vaccination was not reduced in participants as originally hoped for. Nearly 4,000 healthcare workers took part in the BRACE trial across 36 sites from five countries, including the Germans Trias Hospital. Researchers from an IGTP tuberculosis research group were involved in the development of the study, which has been published in the New England Journal of Medicine.

IGTP introduces super-resolution microscope at CMCiB

A state-of-the-art super-resolution fluorescence confocal microscope, called Abberior Infinity, was installed in the high-level biosafety (NCB3) facility of the Centre for Comparative Medicine and Bioimage (CMCiB). The equipment of this class, unique in the region, is a powerful tool for anyone aiming to perform advanced microscopy studies on fully infectious Level 3 pathogens (HIV, SARS-CoV-2, Monkey Pox, TB etc.) The microscope is available for use by all internal and external users via IGTP Microscopy Platform.

- Research

Promising new treatment for childhood liver cancer

A preclinical study with support from the Spanish Association Against Cancer has identified a potential treatment approach for patients with hepatoblastoma, which involves combining standard chemotherapy with a drug currently undergoing clinical trials. The research was conducted using patient samples and animal and laboratory models, and has been led by Dr Josep M. Llovet, professor at the UB and group leader at IDIBAPS, and Dr Carolina Armengol, group leader at IGTP and member of CIBEREHD.

- Innovation, Success Stories

Hyposfix, a new medical device to improve paediatric urological surgeries, has been developed by researchers at Germans Trias Hospital, with support from IGTP

The expertise and innovation spirit of researchers at Germans Trias Hospital's Paediatric Surgery Service has resulted in a new medical device for the treatment of hypospadias: Hyposfix, a urological separator-fixator. This device, which will be launched to market soon, is the result of an idea and a project led at Germans Trias i Pujol Research Institute (IGTP).

- Research

New immunotherapy targeting tumour macrophages to tackle lung cancer

Researchers from the Innate Immunity group at the Germans Trias i Pujol Research Institute (IGTP) have developed a new immunotherapy based on a monoclonal antibody directed against tumour macrophages. The results obtained lay the foundations for a new treatment for patients with lung cancer, with the potential to be applied to other solid tumours. The study has been published in the journal eBioMedicine.

IGTP is appointed as ‘EATRIS Expert Centre’

EATRIS, the European infrastructure for translational medicine, has appointed 7 Expert Centres, to provide high value added services historically offered by EATRIS Coordination and Support. Those expert services that are complementary to the existing laboratory research services offered by EATRIS institutions cover crucial areas such as innovation management, regulatory strategy, translational feasibility, and early health technology assessment. With 7 newly appointed Expert Centres, EATRIS will continue serving Europe's translational research efforts and growing demand for expert services.

- Innovation

Four IGTP spin-offs selected in the WomenTechEU call

The European Commission has announced the results of the second WomenTechEU call, which aims to support innovative European deep-tech companies founded by women. This year, 134 women-led companies have been chosen to receive a €75,000 grant to assist with their innovation process and company growth. Among the selected companies are four spin-offs from the Germans Trias i Pujol Research Institute (IGTP). These companies represent a portion of the 20 Catalan women-led companies selected in the WomenTechEU call.